Back to Journals » Therapeutics and Clinical Risk Management » Volume 15

Once-monthly galcanezumab for the prevention of migraine in adults: an evidence-based descriptive review and potential place in therapy

Total article views   HTML views PDF downloads Totals
9,789 Dovepress* 6,503+ 1,628 8,131
PubMed Central* 3,286 455 3,741
Totals 9,789 2,083 11,872
*Since 11 April 2019

View citations on PubMed Central and Google Scholar